A B S T R A C T
Background. Pulmonary edema is prevalent and may be a common cause of hospital readmissions in hemodialysis patients. We aimed to estimate the national burden of, and identify correlates of, readmissions related to pulmonary edema among hemodialysis patients. Methods. In this retrospective cohort study using national registry data, we identified prevalent US hemodialysis patients (n ¼ 215 251) with index admissions while under Medicare primary coverage in 2011-13. We defined readmissions as admissions occurring within 30 days of the index discharge and pulmonary edema-related readmissions as readmissions with discharge diagnoses of fluid overload, heart failure or pulmonary edema. Multivariable logistic regression models were used to determine odds ratios (ORs) for pulmonary edema-related readmissions by patient and index admission characteristics. Results. About one-quarter (23%) of index hospital admissions were followed by a readmission, with nearly half (44%) of the readmissions being associated with pulmonary edema. The strongest independent correlate of pulmonary edema-related readmission was a pulmonary edema-related index admission [OR ¼ 2.32; 95% confidence interval (CI) 2.22-2.41]. With the exception of dialysis vintage <1 year (OR ¼ 1.18; 95% CI 1.14-1.22), chronic obstructive pulmonary disease (OR ¼ 1.34; 95% CI 1.29-1.38), dialysis non-compliance (OR ¼ 1.53; 95% CI 1.41-1.64) and congestive heart failure (OR ¼ 1.85; 95% CI 1.77-1.93), patient characteristics were not generally associated with higher risk of pulmonary edema-related readmission. Conclusions. Readmissions related to pulmonary edema are common in hemodialysis patients. Interventions aimed at preventing such readmissions could have a substantial impact on readmissions overall, particularly targeted at incident hemodialysis patients with a prior history of heart failure and patients initially admitted for pulmonary edema.
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I N T R O D U C T I O N
More than 400 000 prevalent US end-stage renal disease (ESRD) patients are treated with hemodialysis [1] . Hemodialysis patients are hospitalized frequently (1.7 admissions per year on average), and more than one-third of hospitalizations among hemodialysis patients result in a readmission within 30 days [1] . Because ESRD is one of the strongest risk factors for 30-day readmission among Medicare patients [2] , the Centers for Medicare & Medicaid Services (CMS) has prioritized reduction of hospital readmissions in US dialysis patients [3, 4] . However, few studies have explored readmissions, particularly cause-specific readmissions, in dialysis patients [5] [6] [7] [8] [9] [10] [11] [12] [13] .
Pulmonary edema, seen in the setting of congestive heart failure (CHF) or fluid overload after missed dialysis, dietary indiscretion or inadequate prescribed dry weight [14] , is common in dialysis. In a recent US study, at least 14% of hemodialysis patients experienced one or more treated pulmonary edema episodes over 2 years; >80% of episodes were treated as inpatients versus in the emergency department (ED) [15] . Many investigators have noted that dialysis providers could help reduce pulmonary edema readmission risk via more rapid acquisition and review of hospital records for patients returning to the dialysis facility, reassessment of dry weight and reconciliation of medications [12, [16] [17] [18] [19] . If readmissions due to pulmonary edema are common among dialysis patients, such interventions could have a substantial impact on reducing the overall burden of readmissions. Further, identifying correlates of these readmissions could identify potential targets for such interventions. Thus, we aimed to estimate the national burden of, and identify correlates of, pulmonary edema-related readmissions within 30 days of an index hospitalization among US hemodialysis patients.
M A T E R I A L S A N D M E T H O D S

Study population and data sources
We obtained CMS-2728 and Parts A and B claims data from the United States Renal Data System (USRDS) [1] with approval from the Emory Institutional Review Board. For this retrospective cohort study, analyses were limited to prevalent patients (!120 days from ESRD start at index admission, allowing for the 90-day Medicare eligibility period plus 30-day leadin period), for whom we captured an index admission while on hemodialysis, from 31 January 2011 to 30 November 2013. Of the 320 160 patients with index admissions, we included those who survived !30 days after the index admission discharge (such that they were at risk for readmissions for all 30 days), did not have a transplant or switch to peritoneal dialysis (PD) within 30 days of the index discharge, did not have a transplant prior to index admission and were adults aged 18-99 years at index admission. We further restricted to patients who had primary Medicare coverage at index admission to ensure complete capture of hospital admissions, leaving 215 251 in our final sample (Supplementary data, Figure S1 ).
Study variables
Index admissions. The index admission for each patient was defined as the first admission in the ascertainment period. Admissions that resulted in a discharge to dialysis (discharges to home, home health care, or skilled nursing or intermediate care facility) were included; discharge to acute care facility, death or left against medical advice were excluded. Index admissions were also restricted to admissions that occurred after a period of !30 days with no admissions (Figure 1) , to avoid overestimation due to the inclusion of frequently readmitted patients.
Primary outcome: pulmonary edema-related readmissions. Readmissions were defined as hospital admissions that occurred within 30 days of the index admission discharge. In primary analyses, pulmonary edema-related readmissions were identified via discharge diagnoses International Classification of Diseases, Ninth Revision (ICD-9) codes of fluid overload (276.6, 276.61 or 276.69), heart failure (428.x, 402.x1, 404.x1, 404.x3 or 398.91) or pulmonary edema (518.4 or 514), in any position [15, 20] .
Secondary outcomes: pulmonary edema-related ED visits and observation stays. ED visits were defined by outpatient claims indicating emergency medicine provider type or ED as the place of service. Observation stays were defined by Healthcare Common Procedure Coding System codes G0378, G0379, G0244, G0263, G0264, 99218-99220 and 99234-99236. Pulmonary edema-related ED visits and observation stays were identified via diagnoses codes, as above. A combined outcome of pulmonary edema-related readmission, ED visit or observation stay within 30 days of index discharge was also used. Because US dialysis patients receive Medicare Part A (inpatient, skilled nursing facility, hospice and dialysis services) on the basis of their condition, but voluntarily opt for Medicare Part B coverage (outpatient services, including ED visits), outcomes including ED visits and observations stays only included those patients with Medicare Part B coverage at index admission (n ¼ 212 211).
Potential correlates. Patient age and dialysis vintage at index admission were calculated using the differences between date of admission and dates of birth and first ESRD service. Race/ethnicity, insurance, body mass index (BMI; obesity defined as BMI !30 kg/m 2 ), assigned cause of ESRD and functional impairment (defined as inability to ambulate or transfer, needing assistance with activities of daily living, or institutionalization) were all obtained from the Medicare ESRD eligibility form (CMS-2728). Preexisting conditions were assessed from discharge codes from all hospital discharges in the year up to and including the index admission, using the diagnostic codes outlined in the CMS Chronic Conditions Warehouse algorithms [21] . History of dialysis non-compliance was assessed during the same time period as the comorbid conditions, using ICD-9 code V45.12. For the index admission, length of stay was calculated as the discharge date minus admission date. Cause of index admission was determined by the primary discharge code, using ICD-9 codes as defined by the USRDS (Supplementary data, Table S1 ) [1] . Intensive care utilization was determined by whether patients spent !1 day in an intensive care or coronary care unit during the index admission. Index admission diagnoses and procedures potentially reflecting major catabolic events were identified via ICD-9 codes [severe sepsis (995.92, 785.52), pneumonia (480.x-486.x), coronary artery bypass graft (CABG; 36.1x), lower-limb amputation (84.1x) and burns (940.x-949.x)]. 
Statistical analysis
Patient characteristics were summarized as means and standard deviations (SDs), medians and interquartile ranges (IQRs) or percentages, as appropriate. The burden of readmissions was determined as the percentage of index admissions that resulted in a readmission within 30 days of discharge from the index admission, either overall or attributed to pulmonary edema, using the primary definition described above. Multivariable logistic regression models were used to estimate adjusted odds ratios (ORs) for pulmonary edema-related readmissions for a priori-identified patient and index admission characteristics that might affect risk of readmission. Complete case analysis was used for all models. In secondary analyses, burden of pulmonary edema-related readmissions was also described using: (i) a less sensitive but more specific definition of pulmonary edema-related readmission, in which only codes in the primary position were considered [20] ; and (ii) ED visits and observations stays attributed to pulmonary edema (alone and combined with admissions), all within 30 days of index hospitalization discharge. In additional secondary analyses, we examined the correlates of (iii) primary position-only pulmonary edema-related readmissions [as in (i)] and (iv) both pulmonary edema-related and other readmissions, versus no readmission, using a multinomial logistic regression model. All analyses were performed with Stata v 14.2 (College Station, TX, USA). The statistical significance threshold was set at a ¼ 0.05.
R E S U L T S
Index admission and patient characteristics
Among the 215 251 index admissions included in the study, 21 621 (10%) were followed by a pulmonary edema-related readmission within 30 days (Table 1) . For those who experienced a pulmonary edema-related readmission, 68% also had a pulmonary edema-related index admission ( Table 1) . The study population was 47% female and 37% black, with a mean age at index admission of 64 years. Overall, 24% of patients had been on dialysis for <1 year. Almost 70% of those who experienced a pulmonary edema-related readmission had preexisting CHF, compared with 38% of patients without a pulmonary edemarelated readmission. Severe sepsis, pneumonia, CABG and lower-limb amputations occurred in 1.5, 11.7, 0.8 and 1.8% of index admissions, respectively; burns occurred in <0.01% of index admissions.
Burden of pulmonary edema-related readmissions
Overall, 23% of patients were readmitted and 10% of all index admissions were followed by a pulmonary edema-related readmission (Figure 2A ). Pulmonary edema-related readmissions accounted for 44% of all readmissions ( Figure 2A ) and 70% of readmissions following pulmonary edema-related index admissions ( Figure 2B) .
In secondary analyses, 3% of index admissions were followed by a pulmonary edema-related readmission defined by a discharge code for pulmonary edema in the primary position only, with 11% of all readmissions attributed to pulmonary edema by this definition (Supplementary data, Table S2 ). While one-third (34%) of index admissions were followed by an ED visit or observation stay only, only 5% of these events were pulmonary edema-related. Among all readmissions, ED visits or observation stays in the 30-day post-discharge period, 28% were related to pulmonary edema (Supplementary data, Table S2 ).
Correlates of pulmonary edema-related readmissions
Length of stay of the index admission >4 days was independently associated with 24% higher risk of pulmonary edema-related readmission (Table 2 ). Index admission due to cardiovascular versus other causes was only associated with 11% increased risk of pulmonary edema-related readmission in adjusted analyses, but those with a pulmonary edema-related index admission were 2.3-fold more likely than those with other types of index admissions to be readmitted for pulmonary edema ( Table 2 ). Patient age, sex, race and cause of ESRD were not strongly associated with pulmonary edema-related readmissions. Patients who were on dialysis <1 year versus !1 year at the time of index admission were 18% more likely to experience a pulmonary edema-related readmission. After adjustment, ischemic heart disease, chronic obstructive pulmonary disease and history of dialysis non-compliance were all significantly associated with higher risk of pulmonary edema-related readmissions, while diabetes, cerebrovascular disease and hypertension were not. Preexisting CHF remained associated with 85% higher risk of pulmonary edema-related readmission in the adjusted model. In the fully adjusted model, index admissions involving severe sepsis [OR ¼ 1.22; 95% confidence interval (CI) 1.08-1.37] and pneumonia (OR ¼ 1.16; 95% CI 1.11-1.21) were associated with higher risk of pulmonary edema-related readmission, whereas index admissions involving CABG, lower-limb amputations and burns were not.
In secondary analyses with readmissions related to pulmonary edema as defined in the primary diagnosis position only, the correlates were generally similar to those seen in primary analyses (Supplementary data, Table S3 ). However, by this definition, length of index stay was not associated with pulmonary edema-related readmissions, and the association of CHF with pulmonary edema-related readmissions was weaker (1.4-fold); whereas non-compliance and index admission due to cardiovascular causes versus other causes (2-fold risk for both) were more strongly associated with pulmonary edema-related readmissions, compared with the primary analyses (Supplementary data, Table S3 ). When both pulmonary edema-related and other readmissions were considered in the same model, the association of pulmonary edema-related with index admission and patient characteristics were similar (Supplementary data, Table S4 ). Associations of characteristics with other readmissions were generally similar; however, pulmonary edemarelated index admission and preexisting CHF were associated with 50% and 13% lower risk of other readmission, respectively (Supplementary data, Table S4 ).
D I S C U S S I O N
In this retrospective cohort of prevalent US hemodialysis patients with index admissions in 2011-13, about one-quarter of index admissions were followed by a readmission, with
Pulmonary edema-related readmission in dialysis nearly half of the readmissions being associated with pulmonary edema. The strongest correlate was an index admission that was also related to pulmonary edema, which was independently associated with 2.4-fold risk of pulmonary edema-related readmission, independent of other patient and index admission characteristics. With the exception of shorter dialysis vintage, history of dialysis non-compliance and preexisting chronic obstructive pulmonary disease, ischemic heart disease and, particularly, CHF, we found that patient characteristics were generally not strongly associated with higher risk of pulmonary-edema related readmission.
Recent changes to Medicare payment policies hold both hospitals [3] and dialysis facilities [4] accountable for hospital readmissions among US dialysis patients. Given our finding that a substantial proportion (44%) of readmissions was attributed to pulmonary edema, strategies targeting pulmonary edemarelated readmissions could have a major impact on reducing readmissions overall. Additionally, because the ultrafiltration provided by hemodialysis could help prevent such episodes, dialysis facility providers may have more control over preventing readmissions related to pulmonary edema than readmissions due to other causes, such as respiratory infections or vascular access complications. Further, ultrafiltration during the hospital stay itself that is more aggressive in challenging the patient's dry weight, as tolerated, could also help prevent pulmonary edema-related readmissions. However, challenges remain: patient lack of adherence to salt and fluid intake restrictions [22] and prescribed dialysis [23] [24] [25] [26] and difficulties in provider assessment of fluid status and dry weight [14, 27, 28] can result in pulmonary edema even in the setting of regular hemodialysis. Particularly for patients who were recently hospitalized, undetected changes in dry weight with weight loss, receipt of intravenous medications and/or changes in patient fluid intake could increase risk for readmission due to pulmonary edema. Techniques such as bioimpedance spectroscopy could provide both hospital and dialysis providers with a more sensitive method of detecting subclinical fluid overload [29, 30] ; in fact, in two small randomized trials, dialysis patients whose fluid status was monitored with this technique showed improved cardiovascular parameters relative to those managed with usual practice. However, bioimpedance spectroscopy is not currently widely available to US providers. Furthermore, some patients may be readmitted before they return to the outpatient hemodialysis facility after a hospitalization, limiting the ability of the hemodialysis center to intervene and prevent a pulmonary edema-related readmission [31] . Efforts to reduce pulmonary edema-related readmissions could be more effective if targeted to the patients at highest risk. However, our data suggest that few patient characteristics are associated with these readmissions. For example, we found no substantial differences in the risk of pulmonary edema-related readmissions by patient age, sex or race/ethnicity. In general, even comorbid conditions such as diabetes and hypertension were not substantially associated with risk of pulmonary edema-related readmissions, although it should be emphasized that documentation of preexisting conditions (as captured in Pulmonary edema-related readmission in dialysis these administrative data) does not necessarily capture current severity of the condition, which may be more important than history for readmission risk. For example, blood pressure during admission or at discharge (versus history of hypertension), which was not available in our data, may be a marker of fluid overload and thus a strong risk factor for pulmonary edemarelated readmission. However, preexisting chronic obstructive pulmonary disease (1.3-fold risk), ischemic heart disease (1.2-fold risk), dialysis non-compliance (1.5-fold risk) and, not surprisingly, CHF (1.9-fold risk) were associated with higher risk of pulmonary edema-related readmission. Given the high prevalence of CHF in the US hemodialysis population (44% in 2014) [1] , targeting efforts at this population would be likely be impactful.
We also found that patients who had been on dialysis <1 year were at 18% increased risk of pulmonary edema-related readmissions, compared with patients who had been on dialysis a year or more. This increased risk may be partially attributable to survival bias but may also highlight the vulnerability of patients in the first year of dialysis. A significant number of incident patients have residual kidney function and diuretic use can increase diuresis by 60-100% [32, 33] , offering a strategy to avoid volume overload. However, only one-quarter of US hemodialysis patients are treated with diuretics after dialysis initiation [34] . Targeting efforts (e.g. not only medical treatment but also education on fluid intake and importance of adhering to dialysis regimen) at the initiation of dialysis might reduce pulmonary edema-related readmissions, and potentially overall readmissions.
In general, our results suggest that index admission characteristics are more predictive of pulmonary edema-related readmissions than patient characteristics, which is consistent with prior work on all-cause readmissions in this population [11] . Admissions associated with severe sepsis (1.2-fold), pneumonia (1.2-fold), ICU utilization (1.1-fold) and longer length of stay (1.2-fold) were associated with higher risk of pulmonary edema-related readmissions, indicating that hospitalizations with longer, more complicated courses may lead to major catabolism and, in turn, a pulmonary edema-related readmission in the absence of adequate target weight reassessment. Furthermore, index admissions related to pulmonary edema (2.4-fold risk) were substantially more likely to be followed by a 30-day pulmonary edema-related readmission. The fact that, among these pulmonary edema-related index admissions, 70% of subsequent readmissions were also pulmonary edemarelated suggests a possible substantial failure of care coordination between dialysis facilities and hospitals. More rapid acquisition and review of hospital records for patients returning to the dialysis facility, reassessment of dry weight and medication reconciliation at the dialysis unit could all help reduce readmissions due to pulmonary edema [12, [16] [17] [18] [19] . For example, medication reconciliation was shown to reduce hospitalizations overall [35, 36] and greater numbers of physician visits in the weeks following hospital discharge were associated with decreased all-cause readmission risk in US dialysis patients [6] . Medicare policy changes that encouraged increased face-to-face dialysis physician visits resulted in slight reductions in pulmonary edema-related readmissions, although these changes may have been quite costly [37] .
Data thus far on the effects of the Hospital Readmissions Reduction Program [3] suggest that hospital penalty status is indeed associated with greater gains in hospital performance with respect to readmissions [38, 39] ; the same may be true of penalties for dialysis facilities, implemented in 2017. However, care coordination in the case of a hospitalized dialysis patient is complex and involves multiple providers during and after hospitalizations. While CMS is promoting better care coordination as a means to reduce readmission among dialysis patients within their policy statements [40] , infrastructure in the form of reimbursements for personnel time or establishment of communication systems-an essential element of care coordination in our fractured health system [41] , in which dialysis facilities and hospitals would rarely share an electronic medical record-has not yet been provided.
Several potential limitations deserve mention. Our patient population may not be generalizable to the entire US hemodialysis population, since it includes only those with Medicare primary coverage and excludes patients who have been more likely to be readmitted (e.g. via our requirement for a 60-day admission-free lead-in and exclusion of patients discharged against medical advice). Our exclusion of early deaths and deaths in the 30 days after admission, which may have been associated with pulmonary edema-related readmissions, may have introduced survival bias. While selection bias due to missing data is possible, only 3.1% of observations were dropped due to incomplete data in our multivariable models. With claims data, misclassification is possible. For example, by defining pulmonary edema-related readmissions by a code in any position, we had the highest sensitivity (81.8%) but lowest specificity (77.3%); in contrast, our secondary definition that included only codes in the primary definition had low sensitivity (24.7%) but nearly 100% specificity [20] . However, correlates of pulmonary edema-related readmissions were similar across definitions. Additionally, pulmonary edema may be related not just to excess volume but also to uremia-induced changes in lung permeability [42] ; about two-thirds of non-hospitalized hemodialysis patients may have evidence of lung edema by ultrasound [43] . Different strategies other than those assuming fluid overload would be needed to address such issues. As with any observational study, residual confounding by unmeasured factors is also likely. While we generally found that patient characteristics were not associated with pulmonary edema-related readmissions, there are several patient characteristics that are not well-measured in administrative data, such as education, poverty status, housing situation, social support and mental illness, but could affect this risk. Events that may lead to major catabolism are incompletely captured in the data, with a lack of information on the severity and urgency of conditions; further, length of stay is an imperfect proxy for potential body weight loss during hospitalization. We also do not have detailed process information related to the hospitalization, discharge or return to dialysis facility, such as weight changes during hospitalized dialysis treatments (estimate of adequacy of fluid management in the hospital) and dry weight reassessment and medication reconciliation at the dialysis facility. However, this study does have several strengths, including the capture of all Medicare-primary US patients treated with hemodialysis, limited loss to follow-up due to universal coverage of ESRD services and availability of claims data for all inpatient and outpatient services after start of dialysis.
Readmissions related to pulmonary edema are common in hemodialysis patients. Interventions aimed at preventing such readmissions, potentially targeted at incident patients with CHF and/or at patients admitted for pulmonary edema, could have a substantial impact on readmissions overall. For dialysis facilities and hospitals, who are now accountable for readmissions among their hemodialysis patients, pragmatic trials may be needed to determine how best to reduce these burdensome readmissions in real-world clinical settings.
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